IRB Barcelona logo

Research

At the forefront of biomedicine

Francisco Fuster

Unit:
Position:
Alumni -
Visiting Scientist
Office:
CL01C74
Telephone:
+34 93 40 39954
Left IRB Barcelona in March 2022
Research Group

Selected group publications

TP53-dependent toxicity of CRISPR/Cas9 cuts is differential across genomic loci and can confound genetic screening
Alvarez, MM; Biayna, J; Supek, F
Nature Communications
13
(1 )
4520 -
(2022)
The impact of rare germline variants on human somatic mutation processes
Vali-Pour M, Park S, Espinosa-Carrasco J, Ortiz-Martínez D, Lehner B, Supek F
Nature Communications
13
(1 )
3724 -
3724
(2022)
Mutational signatures are markers of drug sensitivity of cancer cells
Levatić J, Salvadores M, Fuster-Tormo F, Supek F
Nature Communications
13
(1 )
2926 -
2926
(2022)
Loss of the abasic site sensor HMCES is synthetic lethal with the activity of the APOBEC3A cytosine deaminase in cancer cells
Biayna J; Garcia-Cao I; Álvarez MM; Salvadores M; Espinosa-Carrasco J; McCullough M; Supek F; Stracker TH
Plos Biology
19
(3 )
e3001176 -
(2021)
DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers
Mas-Ponte D; Supek F
Nature Genetics
52
(9 )
958 -
+
(2020)